Want to see BENF full AI Analyst Report?
Top Page
Beneficient
(NASDAQ:BENF)
Select Model
Select Model
Rating:41Neutral
Price Target:
$2.50
▼(-23.08% Downside)
Action:Reiterated
Date:08/17/26
BENF scores low primarily due to weak financial performance—material operating losses and sustained negative free cash flow dominate despite a cleaner, debt-free balance sheet. Technicals also weigh on the score with a clear downtrend (price below key moving averages and negative MACD), partially offset by near-oversold momentum. Valuation provides limited support because the negative P/E reflects ongoing losses and there is no dividend yield data.
Positive Factors
Debt-Free Balance Sheet
The latest TTM balance sheet has no debt and $90.5M of positive equity, improving near-term solvency and reducing creditor pressure. However, prior strain means the durability of this improvement still requires monitoring.
Negative Factors
Deep Operating Losses
Current revenue is insufficient to support the cost base, producing substantial operating and net losses. Persistent unprofitability limits internal capital formation and makes sustainable scaling dependent on improved economics or external funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-Free Balance Sheet
The latest TTM balance sheet has no debt and $90.5M of positive equity, improving near-term solvency and reducing creditor pressure. However, prior strain means the durability of this improvement still requires monitoring.
Read all positive factors
Beneficient (BENF) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$34.93M
Dividend YieldN/A
Average Volume (3M)23.74M
Price to Earnings (P/E)―
Beta (1Y)0.65
Revenue Growth-38.32%
EPS Growth94.03%
CountryUS
Employees50
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)-47.16
Shares Outstanding15,425,814
10 Day Avg. Volume1,028,732
30 Day Avg. Volume23,735,752
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.02
Price to Sales (P/S)-0.12
P/FCF Ratio-0.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.89
Revenue Forecast (FY)$38.51M
Beneficient Business Overview & Revenue Model
Company Description
Beneficient operates as a technology-driven financial services provider, specializing in delivering liquidity solutions to entities within the alternative asset market. The company manages the AltAccess platform, a comprehensive digital ecosystem ...
How the Company Makes Money
Beneficient’s revenue model is tied to facilitating liquidity and financing solutions for illiquid alternative assets. Its earnings are generally expected to come from transaction-based economics (e.g., fees or spreads earned when arranging or com...
Beneficient Earnings Call Summary
Earnings Call Date:Feb 17, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Nov 12, 2026
Earnings Call Sentiment Negative
The call described several important stabilizing and corrective actions — regaining NASDAQ compliance, a GWG settlement within insurance limits, cost reductions (6.5% quarter, 18% YTD), $50M in proceeds and targeted debt paydowns — that position the company to rebuild momentum. However, these positives are counterbalanced by material operational and financial challenges: large quarterly and year-to-date operating losses, negative adjusted revenues, substantial declines in investments and NAV (roughly 29% and ~32%, respectively), reduced interest income (down ~25% YTD), low cash versus ~$100M of debt largely tied to former CEO-related entities, and ongoing legal uncertainty tied to the former CEO. Given the scale of the financial deterioration and lingering legal/balance-sheet risks relative to the accomplishments, the negatives outweigh the positives.Positive Updates
Regained NASDAQ Compliance
Beneficient regained full compliance with NASDAQ continued listing requirements in January after completing an annual audit, filing multiple periods in a compressed timeframe, improving balance sheet equity and increasing stock price to meet the minimum listing threshold.
Negative Updates
Substantial Operating Loss
Operating loss for the fiscal third quarter was $29.2 million (worse than the prior quarter operating loss of $0.8 million sequentially). Year-to-date operating loss was $36.0 million versus $0.5 million in the prior year period.
Read all updates
Q3-2026 Updates
Positive
Negative
Regained NASDAQ Compliance
Beneficient regained full compliance with NASDAQ continued listing requirements in January after completing an annual audit, filing multiple periods in a compressed timeframe, improving balance sheet equity and increasing stock price to meet the minimum listing threshold.
Read all positive updates
Company Guidance
Management’s forward guidance emphasized stabilizing and re‑scaling the core liquidity and GP primary‑financing business while continuing expense and capital‑structure simplification: they plan further expense reductions after already cutting adjusted operating expenses 6.5% year‑over‑year and 18% year‑to‑date (ex. one‑time items), intend to close additional liquidity and GP primary financings (having closed a ~$3.0M NAV deal in December) and to act on a spring pipeline of opportunities, and will leverage a technology/AI‑enhanced platform to increase loan‑portfolio capacity (current net loan portfolio $188M, investments at fair value ~$206M). Management also reiterated balance‑sheet priorities — having generated about $50M gross proceeds from asset sales/redemptions (used in part to reduce debt, including ~$27.5M to a Texas State Bank), ending the quarter with $7.9M cash and $100.3M total debt (all but $3.7M tied to the former CEO’s entities) — and said it will consider litigation to challenge over $100M (≈$120M) of purported debt; they noted a $44.1M fair‑value increase in a derivative that settles in January 2028 and signaled plans to broaden channels (advisers, family offices, private banks) and demonstrate the business via a handful of transactions.Beneficient Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
34
Negative
Cash Flow
18
Very Negative
| Breakdown | TTM | Mar 2026 | Jun 2025 | Jun 2024 | Mar 2023 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.65M | -39.13M | -7.95M | -98.91M | -104.99M | 101.98M |
| Gross Profit | 17.89M | -859.00K | -24.80M | -164.04M | -150.52M | 81.20M |
| EBITDA | -50.00M | -144.97M | -35.40M | -2.64B | -234.09M | -13.81M |
| Net Income | -29.13M | -87.43M | 51.16M | -2.10B | -130.98M | -58.04M |
Balance Sheet | ||||||
| Total Assets | 250.94M | 238.77M | 354.88M | 368.50M | 368.50M | 3.14B |
| Cash, Cash Equivalents and Short-Term Investments | 5.58M | 2.54M | 1.35M | 7.91M | 7.91M | 70.59M |
| Total Debt | 0.00 | 96.78M | 117.90M | 130.25M | 130.25M | 171.59M |
| Total Liabilities | 344.50M | 337.53M | 299.27M | 309.57M | 309.57M | 241.43M |
| Stockholders Equity | 90.53M | -214.02M | -167.00M | -234.35M | -234.35M | 1.44B |
Cash Flow | ||||||
| Free Cash Flow | -66.99M | -38.81M | -38.80M | -59.98M | -97.19M | -57.23M |
| Operating Cash Flow | -66.72M | -38.72M | -37.70M | -58.22M | -95.12M | -54.01M |
| Investing Cash Flow | 100.91M | 61.21M | 28.11M | 44.06M | 63.02M | -5.98M |
| Financing Cash Flow | -29.70M | -21.29M | 2.97M | 12.59M | -34.46M | 43.86M |
Beneficient Technical Analysis
Negative
3.25
Price Trends
3.18
Negative
3.32
Negative
4.03
Negative
Market Momentum
-0.28
Positive
31.99
Neutral
14.46
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BENF, the sentiment is Negative. The current price of 3.25 is above the 20-day moving average (MA) of 2.76, above the 50-day MA of 3.18, and below the 200-day MA of 4.03, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 31.99 is Neutral, neither overbought nor oversold. The STOCH value of 14.46 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BENF.
Beneficient Risk Analysis
Beneficient disclosed 131 risk factors in its most recent earnings report. Beneficient reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Beneficient Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $23.88M | 7.94 | 30.08% | ― | 7.20% | ― | |
47 Neutral | $37.03M | -0.45 | -61.99% | 2.85% | 44.90% | -447.95% | |
44 Neutral | $5.43M | -0.11 | 641.51% | ― | -49.72% | 78.89% | |
41 Neutral | $34.93M | -0.05 | 22.15% | ― | -38.32% | 94.03% | |
34 Underperform | $6.48M | >-0.01 | 1.94% | ― | ― | -8154.56% |
* Financial Sector Average
BENF
Beneficient
2.26
-0.85
-27.33%
BTTC
Black Titan
0.60
-4.34
-87.83%
BCG
Binah Capital Group
1.40
-0.58
-29.22%
CWD
CaliberCos, Inc. Class A
0.52
-1.26
-70.67%
MLCI
Mount Logan Capital Inc
3.31
-4.46
-57.38%
Beneficient Corporate Events
Private Placements and Financing
Beneficient Issues Convertible Notes Under Amended Yorkville Deal
Neutral
Aug 11, 2026
On June 26, 2026, Beneficient amended and restated its Standby Equity Purchase Agreement with Yorkville, reducing the total available commitment to up to $100 million of Class A common stock and arranging for $4 million in convertible promissory n...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Beneficient expands AI-focused GP primary capital program
Positive
Jul 13, 2026
On July 10, 2026, Beneficient closed a $7.44 million primary capital transaction with Quartus AI Fund II LP, an AI-focused fund managed by New York-based Quartus Capital Partners, issuing $7.44 million in Series B-11 Resettable Convertible Preferr...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Beneficient Amends Yorkville Financing, Issues New Convertible Note
Neutral
Jul 7, 2026
On June 26, 2026, Beneficient amended and restated its Standby Equity Purchase Agreement with Yorkville, reducing the total available equity commitment from $250 million to $100 million and adding a $4 million tranche of convertible promissory not...
Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresLegal ProceedingsPrivate Placements and FinancingRegulatory Filings and Compliance
Beneficient Reports Q4 Results, Appoints Permanent CEO
Positive
Jun 29, 2026
Beneficient reported results for its fourth quarter and fiscal year ended March 31, 2026, highlighting a year of balance sheet repair and operational refocusing as disclosed on June 29, 2026. The company resolved litigation related to GWG Holdings...
Business Operations and StrategyExecutive/Board ChangesProduct-Related Announcements
Beneficient Launches First Collateral Management Engagement With Bank
Positive
Jun 25, 2026
On June 25, 2026, Beneficient announced its first engagement to provide collateral management services to a Texas state-chartered bank in connection with a secured lending transaction backed by professionally managed alternative assets. Under this...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.